ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

M. Adamina*, S. Bonovas, T. Raine, A. Spinelli, J. Warusavitarne, A. Armuzzi, O. Bachmann, P. Bager, L. Biancone, B. Bokemeyer, P. Bossuyt, J. Burisch, P. Collins, G. Doherty, A. El-Hussuna, P. Ellul, G. Fiorino, C. Frei-Lanter, F. Furfaro, C. GingertP. Gionchetti, J.P. Gisbert, F. Gomollon, M.G. Lorenzo, H. Gordon, T. Hlavaty, P. Juillerat, K. Katsanos, U. Kopylov, E. Krustins, T. Kucharzik, T. Lytras, C. Maaser, F. Magro, J.K. Marshall, P. Myrelid, G. Pellino, I. Rosa, J. Sabino, E. Savarino, L. Stassen, J. Torres, M. Uzzan, S. Vavricka, B. Verstockt, O. Zmora, F. Akyuz, R. Atreya, M.B. De Acosta, D. Bettenworth, European Crohn’s Colitis Organisation (ECCO)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

370 Downloads (Pure)

Abstract

This article is the second in a series of two publications relating to the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article covers medical management; the present article addresses surgical management, including preoperative aspects and drug management before surgery. It also provides technical advice for a variety of common clinical situations. Both articles together represent the evidence-based recommendations of the ECCO for Crohn's disease and an update of previous guidelines.
Original languageEnglish
Pages (from-to)155-168
Number of pages14
JournalJournal of Crohn's & Colitis
Volume14
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • anti-tnf therapy
  • crohn's disease
  • evidence-based consensus
  • fecal diversion
  • inflammatory bowel disease [ibd]
  • inflammatory-bowel-disease
  • intersphincteric fistula tract
  • intraabdominal septic complications
  • postoperative complications
  • pouch-anal anastomosis
  • surgery
  • to-end anastomosis
  • vedolizumab-treated patients
  • INTERSPHINCTERIC FISTULA TRACT
  • EVIDENCE-BASED CONSENSUS
  • POSTOPERATIVE COMPLICATIONS
  • inflammatory bowel disease [IBD]
  • FECAL DIVERSION
  • VEDOLIZUMAB-TREATED PATIENTS
  • ANTI-TNF THERAPY
  • Crohn's disease
  • INTRAABDOMINAL SEPTIC COMPLICATIONS
  • INFLAMMATORY-BOWEL-DISEASE
  • TO-END ANASTOMOSIS
  • POUCH-ANAL ANASTOMOSIS

Fingerprint

Dive into the research topics of 'ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment'. Together they form a unique fingerprint.

Cite this